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After publication of the original article [1], it came to
the authors’ attention that there were errors in Fig. 3,
Fig. 4 and Additional file 1: Figure S1.
In each Figure, panels A, B and C are not correct (but
panels D, E and F are). This error was due to a mistake
in the last stages of the submission process while adjusting
the Figures’ size to fit the journal’s requirements. This
error does not impact the results, discussion and
conclusions of the paper.
The correct version of the affected Figures are
published in this erratum.
Additional file
Additional file 1: Figure S1. (A) Functional principal component
analysis using Fourier basis functions with no smoothing. (B) Functional
principal component analysis using Fourier basis functions with common
−optimal smoothing. (C) Functional principal component analysis using
Fourier basis functions with individual−optimal smoothing. (D) Functional
principal component analysis using B−spline basis functions with no
smoothing. (E) Functional principal component analysis using B−spline
basis functions with common−optimal smoothing. (F) Functional
principal component analysis using B−spline basis functions with
individual−optimal smoothing. (PDF 27 kb)
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Fig. 3 Bootstrapping confidence intervals (CIs) resulting from functional principal component analysis (FPCA) on 1000 re-samples obtained by a
random sample with repetition from the original data sets. Panel a – Bootstrapping CI resulting from a FPCA using Fourier basis functions and no
smoothing parameter; Panel b – Bootstrapping CI resulting from a FPCA using Fourier basis functions and common-optimal smoothing parameter;
Panel c – Bootstrapping CI resulting from a FPCA using Fourier basis functions and individual-optimal smoothing parameter; Panel d – Bootstrapping
CI resulting from a FPCA using B-splines basis functions and no smoothing parameter; Panel e – Bootstrapping CI resulting from a FPCA
using B-splines basis functions and common-optimal smoothing parameter; Panel f – Bootstrapping CI resulting from a FPCA using
B-splines basis functions and individual-optimal smoothing parameter
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Fig. 4 (See legend on next page.)
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Fig. 4 Sensitivity to missing for functional principal component analysis (FPCA) results. Panel a – Functional principal components (FPCs) resulting
from a FPCA using Fourier basis functions and no smoothing parameter for 5, 10, 15, 20 % of missing; Panel b – Functional principal components
(FPCs) resulting from a FPCA using Fourier basis functions and common-optimal smoothing parameter for 5, 10, 15, 20 % of missing; Panel c – Functional
principal components (FPCs) resulting from a FPCA using Fourier basis functions and individual-optimal smoothing parameter for 5, 10,
15, 20 % of missing; Panel d – Functional principal components (FPCs) resulting from a FPCA using B-splines basis functions and no
smoothing parameter for 5, 10, 15, 20 % of missing; Panel e – Functional principal components (FPCs) resulting from a FPCA using
B-splines basis functions and common-optimal smoothing parameter for 5, 10, 15, 20 % of missing; Panel f – Functional principal
components (FPCs) resulting from a FPCA using B-splines basis functions and individual-optimal smoothing parameter for 5, 10, 15,
20 % of missing
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